Purchase Order SPE2DP25V1855
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a firm fixed-price purchase order valued at $1,809.47 to SZY Holdings, LLC for Nirmatrelvir and related pharmaceutical supplies. The contract, issued on August 22, 2025, with an ultimate completion date of October 30, 2025, represents a direct procurement with no small business set-aside designation. SZY Holdings, a for-profit limited liability company headquartered in Brooklyn, New York, will perform the work at its...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $5,465.31 firm fixed-price purchase order to SZY Holdings, LLC on May 2, 2025, for Nirmatrelvir and related pharmaceutical supplies. The contract, which requires completion by July 10, 2025, was awarded without set-aside designation to the Brooklyn, New York-based medical equipment and supplies manufacturer. SZY Holdings will perform work at its facility in Brooklyn, New York. SZY Holdings, LLC is an established...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a $1,840 firm fixed-price purchase order to SZY Holdings, LLC for Nirmatrelvir and Ritonavir (an antiviral pharmaceutical treatment) on March 12, 2025. The contract, which carries no set-aside designation, is scheduled for completion by May 20, 2025, with performance taking place at the vendor's facility in Brooklyn, New York. SZY Holdings, a for-profit limited liability company and registered small business, will...
- This contract award to SZY Holdings, LLC is for the supply of NIRMATRELVIR AND RI medical products to the Defense Logistics Agency (DLA), specifically the Troop Support Medical division. The firm-fixed-price purchase order, valued at $3,677.90, has an ultimate completion date of May 22, 2025. SZY Holdings, LLC is a for-profit limited liability company that primarily operates as a defense contractor, supplying a range of medical equipment, supplies, and pharmaceuticals to various DLA divisions....
- This federal contract award is for the purchase of NIRMATRELVIR AND RI medical supplies by the Defense Logistics Agency (DLA). The contract was awarded to SZY Holdings, LLC, a for-profit limited liability company and manufacturer of medical equipment, supplies, and consumables, with a place of performance in Brooklyn, NY. The contract has a ceiling value of $1,872.66 and is a firm fixed-price purchase order, with an ultimate completion date of April 14, 2025. The contract is not set aside for...
- This is a $9,200.00 firm-fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to SZY Holdings, LLC, a for-profit limited liability company, for the provision of NIRMATRELVIR AND RI medical supplies. The contract has an ultimate completion date of May 12, 2025. SZY Holdings, LLC is a manufacturer and supplier of a diverse range of medical products to various DLA divisions, with a focus on supporting military health programs. The contract is not set aside for any...
- This is a $1,014 firm-fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The contract is for the delivery of ARTEMETHER-LUMEFANT medical supplies, with a completion date of August 14, 2025. SZY Holdings is a manufacturer of medical equipment, supplies, and consumables, primarily serving federal government agencies. This award does not have a set-aside designation. SZY Holdings has been...
- SZY Holdings LLC has been awarded a purchase order contract from the Defense Logistics Agency Troop Support Medical to provide nystatin and neomycin products. With a potential value of $1,189.08, this firm fixed price contract has a period of performance through September 18, 2023 for delivery to a location in Brooklyn, New York. As a for-profit limited liability company and manufacturer, SZY Holdings LLC regularly supplies medical devices, consumables, and pharmaceuticals to various...
- SZY Holdings, LLC, a Brooklyn, New York-based small business manufacturer, was awarded a purchase order by the Defense Logistics Agency's Medical Supply Chain division on December 19, 2025, for hydrochlorothiazide with a ceiling value of $1,746.69 under a firm fixed-price contract structure. The contract, designated as a non-set-aside procurement, carries an ultimate completion date of February 23, 2026, and represents a routine pharmaceutical supply acquisition to support federal healthcare and...
- SZY Holdings, LLC, doing business as SZY Holdings LLC, has been awarded a purchase order contract valued at forty-nine thousand dollars by the Defense Logistics Agency Troop Support Medical (DLA) to provide medicine and medical supplies. The firm fixed price contract has a period of performance starting on September 19, 2023 through October 10, 2023 for items to be delivered to a location in Brooklyn, New York. DLA is a combat logistics support agency within the Department of Defense that...
The U.S. Defense Logistics Agency (DLA), Medical Supply Chain division, awarded a firm fixed-price purchase order valued at $3,648 to SZY Holdings, LLC for Nirmatrelvir and related pharmaceutical products. The contract was awarded on April 25, 2025, with an ultimate completion date of June 30, 2025. SZY Holdings, a medical equipment and supplies manufacturer based in Brooklyn, New York, will perform the work at its Brooklyn facility. This award was not designated as a set-aside contract and represents a standard procurement action consistent with DLA's routine medical supply acquisition activities. SZY Holdings, LLC brings substantial federal contracting experience to this engagement, having maintained active registration in the System for Award Management since 2006 and maintaining an established track record with the DLA across multiple divisions and procurement vehicles. The company specializes in supplying pharmaceuticals and medical consumables to support U.S. military health programs and has previously secured both standard purchase orders and small business set-aside contracts through DLA. This award exemplifies the continued reliance on qualified commercial vendors to fulfill critical pharmaceutical procurement needs within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 4/25/25 |